Laboratory of Polypeptide Drugs and Delivery - Dr Peter Moyle

Laboratory of Polypeptide Drugs and Delivery - Dr Peter Moyle The Laboratory of Polypeptide Drugs and Delivery (Dr Peter Moyle) is located at the University of Queensland Pharmacy Australia Centre of Excellence (PACE)

The Laboratory of Polypeptide Drugs and Delivery is headed by Dr Peter Moyle at the University of Queensland’s Pharmacy Australia Centre of Excellence (PACE) at Woolloongabba next door to the Translational Research Institute. The lab focuses on the combined use of synthetic and recombinant peptides and proteins for: 1) the development of new drugs, with a particular focus on vaccines; 2) decoding biochemical pathways (e.g. posttranslational modifications), to discover new drugable targets; 3) developing delivery systems to improve the stability, oral absorption, targeting, and cellular uptake of potential peptide and protein drugs; 4) using peptide technology to develop novel delivery systems (e.g. for the treatment of diabetes, and the delivery of gene technology).

21/02/2023

Want to advance your pharmacy career with a PhD? Applications for the Alan Grant-Taylor Memorial Scholarship are now open, with up to $42,192 p.a. available with the UQ School of Pharmacy for candidates to conduct research in the field of community pharmacy practice. Applications close 26 March 2023. Find out more: https://fal.cn/3vZkt

Exciting funded PhD Scholarship opportunity on targeted gene delivery platforms. Find further information at
21/02/2020

Exciting funded PhD Scholarship opportunity on targeted gene delivery platforms. Find further information at

Find A PhD. Search Funded PhD Projects, Programs & Scholarships at University of Queensland, School of Pharmacy.

  international     applications close Jan 17 2020 https://bit.ly/352Gk53. Looking for applicants to work on ARC     pro...
08/12/2019

international applications close Jan 17 2020 https://bit.ly/352Gk53. Looking for applicants to work on ARC project. See http://moylelab.com for information and contact details

The UQ Graduate School manages a number of scholarship schemes that provide financial support for tuition fees, living costs and travel which enables you to focus on your research.

05/12/2019

Congratulations to PhD student Zhenghui Xu on the submission of your thesis and the publication of your 1st research article in the prestigious Journal of Controlled Release.

His publication describes a simple, efficient Sortase A enzyme-mediated means to site-specifically conjugate Toll-like receptor 2 agonist lipopeptide adjuvants onto recombinant protein antigens.

Australian Research Council (ARC) Grant Success:We thank the Australian Research Council and the Australian Government f...
05/12/2019

Australian Research Council (ARC) Grant Success:

We thank the Australian Research Council and the Australian Government for awarding our laboratory and collaborators (Prof Toth, UQ) with a 2020 ARC Discovery Project Grant for 3 years.

We look forward to the research and training opportunities that this funding will provide.

Project Summary: Developing a multicomponent platform for targeted gene delivery. Gene delivery systems are important tools in biological research and offer many exciting future prospects. Delivering gene material is very difficult in practice: rapid deterioration, poor cell uptake, and reaching the right tissue and cell types are major obstacles. Ways to overcome each barrier individually have been suggested in existing research but these components have not yet been combined in a single solution, which this project will tackle. This proposal aims to create a technology to stabilise and deliver active gene material to target cells. The gene delivery tool developed in this project will advance biological research greatly with many potential future applications.

RMS is the ARC’s Research Management System, a web-based system used by eligible researchers to prepare and submit research proposals and assessments under the ARC National Competitive Grants Program (NCGP).

02/05/2019
25/09/2017

See our latest review on biotechnology approaches to produce potent, self-adjuvanting antigen-adjuvant fusion protein subunit vaccines in Biotechnology Advances

Traditional vaccination approaches (e.g. live attenuated or killed microorganisms) are among the most effective means to prevent the spread of infectious diseases. These approaches, nevertheless, have failed to yield successful vaccines against many important pathogens. To overcome this problem, met...

Read about our exciting new breast cancer targeted siRNA/pDNA delivery platform
25/09/2017

Read about our exciting new breast cancer targeted siRNA/pDNA delivery platform

The development of carriers for the delivery of oligonucleotide therapeutics is essential for the successful translation of gene therapies to the clinic. In the present study, a delivery system, which combines the fusogenic lipid 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) with a well-defin...

Congratulations to Zhenghui Xu on the acceptance and publication of his review on bioconjugation approaches to produce s...
25/09/2017

Congratulations to Zhenghui Xu on the acceptance and publication of his review on bioconjugation approaches to produce self-adjuvanting vaccines in Bioconjugate Chemistry

Bioconjugation Approaches to Producing Subunit Vaccines Composed of Protein or Peptide Antigens and Covalently Attached Toll-Like Receptor Ligands

Congratulations to Anjuman Begum for her recently accepted publication comparing the expression of the bombesin receptor...
20/09/2016

Congratulations to Anjuman Begum for her recently accepted publication comparing the expression of the bombesin receptor on different cell lines to uptake of bombesin peptides.

Link:

Targeted drug delivery provides a means to improve efficacy, while reducing side effect and the dose of drug that needs to be delivered. The bombesin peptide is a potential targeting moiety for various types of cancers. However, the development of targeted delivery systems requires highly characteri...

24/07/2016

See our latest article on optimising -L-lysine for http://bit.ly/2a2QNGq

Gene therapy is a promising means to treat or prevent diseases either through gene silencing or expression. Some of the most effective delivery agents are polycationic dendrimers, which are highly branched constructs incorporating many positively charged groups. Two of the most effective dendrimers…

Address

20 Cornwall Street
Brisbane, QLD
4102

Alerts

Be the first to know and let us send you an email when Laboratory of Polypeptide Drugs and Delivery - Dr Peter Moyle posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram